Panayotis Fasseas, MD
Interventional Cardiology · Milwaukee, WINPI 1407800709
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Boston Scientific at 36.0% of the total. 2025 is the largest year on record at $159, 4.9 times the $32 reported in 2020. That places this record below the midpoint for interventional cardiology clinicians in WI, where the typical reported total is $3,713.
Across 14 payments — averaging $24.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$126
- Medtronic$118
- Cardiva Medical, Inc.$52
- Heartflow, Inc.$25
- Teleflex LLC$16
- W. L. Gore & Associates, Inc.$14
Across 28 payments — averaging $2655.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$59K
- Edwards Lifesciences$15K
What the payments were for
- Food & beverage$350100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $126 |
| Medtronic | 4 | $118 |
| Cardiva Medical, Inc. | 2 | $52 |
| Heartflow, Inc. | 1 | $25 |
| Teleflex LLC | 1 | $16 |
| W. L. Gore & Associates, Inc. | 1 | $14 |
How this compares
$350 in reported general payments places this provider in the 15th percentile of 118 interventional cardiology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 11 | $22,475 |
| Repatha SureclickEvolocumab | 30 | $19,745 |
| BrilintaTicagrelor | 11 | $4,653 |
| Metoprolol Succinate | 48 | $542 |
| Atorvastatin Calcium | 41 | $294 |
| Warfarin Sodium | 30 | $256 |
| Lisinopril | 27 | $158 |
| Losartan Potassium | 17 | $154 |
| Rosuvastatin Calcium | 13 | $136 |
| Metoprolol Tartrate | 17 | $79 |
| Amlodipine Besylate | 16 | $71 |
| Furosemide | 22 | $48 |
| Pantoprazole Sodium | 14 | $12 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Milwaukee
- Michael SalingerMilwaukee$216K
- Tanvir BajwaMilwaukee$106K
- Suhail AllaqabandMilwaukee$88K
- Saif AnwaruddinMilwaukee$80K
- Iyad AzzamMilwaukee$60K
- Montoya TaylorMilwaukee$48K
- Mina IskanderMilwaukee$41K
- Anna LarosaMilwaukee$38K
- Louie KostopoulosMilwaukee$26K
- Daniel JohnsrudMilwaukee$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.